iXCells Biotechnologies USA, Inc.
Accelerating the pace of drug discovery.
At iXCells Biotechnologies, each product and service is designed to empower researchers with innovative solutions that accelerate drug discovery workflows with a focus on neurodegenerative / CNS disease models.
Headquartered in San Diego, CA, iXCells Biotechnologies is a leading cell technology developer and manufacturer of human cells leveraging iPSC innovation for preclinical drug discovery solutions with a focus on disease relevant cellular models.
We offer enabling technologies and services to a broad array of clients in the academic, biotechnology and pharmaceutical communities by providing high quality primary cells, normal and diseased iPS cell lines, iPSC-derived cell products, custom iPSC services, functional bioassay development and execution, and more.
From our earliest days, we’ve always aspired to transform human health by unlocking the potential of induced pluripotent stem cells. At iXCells, each new product and service is designed to empower researchers with innovative solutions that accelerate drug discovery workflows, with a focus on neurodegenerative / CNS disease models.
Specific Areas of Expertise
IPSC | Primary Cells | Genome Editing | Cell-based Bioassays | Organotypic Culture Models | Patient-derived iPSC Generation | Drug Discovery | Directed Differentiation | Disease-in-a-dish | Cellular Model | Immunoassays | ASO Screening